← Fátima Rodríguez

Papers by Fátima Rodríguez

Page 3 · newest first

101. How Low Can You Go? New Evidence Supports No Lower Bound to Low-Density Lipoprotein Cholesterol Level in Secondary PreventionCirculation · 2023
102. Clinical Trial Technologies for Improving Equity and Inclusion in Cardiovascular Clinical ResearchCardiology and Therapy · 2023
103. Natural language processing to identify reasons for sex disparity in statin prescriptionsAmerican Journal of Preventive Cardiology · 2023
104. Longitudinal Trends in Cardiovascular Risk Factor Profiles and Complications Among Patients Hospitalized for COVID-19 Infection: Results From the American Heart Association COVID-19 Cardiovascular Disease RegistryCirculation Cardiovascular Quality and Outcomes · 2023
105. Identifying Reasons for Statin Nonuse in Patients With Diabetes Using Deep Learning of Electronic Health RecordsJournal of the American Heart Association · 2023
106. Locking the Revolving Door: Racial Disparities in Cardiovascular DiseaseJournal of the American Heart Association · 2023
107. Circulating ketone bodies and cardiovascular outcomes: the MESA studyEuropean Heart Journal · 2023
108. Appropriateness of Cardiovascular Disease Prevention Recommendations Obtained From a Popular Online Chat-Based Artificial Intelligence ModelJAMA · 2023
109. Real-World Practice Patterns Reveal <1% Adoption of Recommended Genetic Testing for Inherited CardiomyopathiesAmerican Journal of Preventive Cardiology · 2023
110. Health Techequity: Opportunities for Digital Health Innovations to Improve Equity and Diversity in Cardiovascular CareCurrent Cardiovascular Risk Reports · 2022
111. Sociodemographic determinants of oral anticoagulant prescription in patients with atrial fibrillations: findings from the PINNACLE registry using machine learningHeart Rhythm O2 · 2022
112. Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)Circulation · 2022
113. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial FibrillationJAMA Cardiology · 2022
114. Drivers of variation in telemedicine use during the COVID-19 pandemic: The experience of a large academic cardiovascular practiceJournal of Telemedicine and Telecare · 2022
115. Association between Obesity and Length of COVID-19 Hospitalization: Unexpected Insights from the American Heart Association National COVID-19 RegistryJournal of Obesity & Metabolic Syndrome · 2022
116. LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goalsPostgraduate Medicine · 2022
117. Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018JAMA · 2022
118. Association Between Social Vulnerability Index and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System StudyThe Medicine Forum · 2022
119. Multi-dimensional characterization of prediabetes in the Project Baseline Health StudyCardiovascular Diabetology · 2022
120. County-Level Social Vulnerability is Associated With In-Hospital Death and Major Adverse Cardiovascular Events in Patients Hospitalized With COVID-19: An Analysis of the American Heart Association COVID-19 Cardiovascular Disease RegistryCirculation Cardiovascular Quality and Outcomes · 2022
121. Using deep learning-based natural language processing to identify reasons for statin nonuse in patients with atherosclerotic cardiovascular diseaseCommunications Medicine · 2022
122. Trends in national and county-level Hispanic mortality in the United States, 2011–2020Scientific Reports · 2022
123. Terpenes Combinations Inhibit Biofilm Formation in Staphyloccocus aureus by Interfering with Initial Adhesion2022
124. Review of Lipid-Lowering Therapy in Women from Reproductive to Postmenopausal YearsReviews in Cardiovascular Medicine · 2022
125. Sex-Specific Risk Factors Associated With First Acute Myocardial Infarction in Young AdultsJAMA Network Open · 2022
126. Race/ethnicity reporting and representation in US clinical trials: A cohort studySHILAP Revista de lepidopterología · 2022
127. Cardiovascular Disease Mortality Among Hispanic Versus Non‐Hispanic White Adults in the United States, 1999 to 2018Journal of the American Heart Association · 2022
128. Changes in telemedicine use and ambulatory visit volumes at a multispecialty cardiovascular center during the COVID-19 pandemicJournal of Telemedicine and Telecare · 2022
129. COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohortPLoS ONE · 2022
130. Personalizing cholesterol treatment recommendations for primary cardiovascular disease preventionScientific Reports · 2022
131. Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular DiseaseJAMA Cardiology · 2022
132. Screening for participants in the ISCHEMIA trial: Implications for clinical researchJournal of Clinical and Translational Science · 2022
133. N‐Terminal Pro‐B‐Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID‐19 in a Nationwide Hospitalized CohortJournal of the American Heart Association · 2021
134. Major disparities in COVID-19 test positivity for patients with non-English preferred language even after accounting for race and social factors in the United States in 2020BMC Public Health · 2021
135. National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999–2019)Circulation · 2021
136. Association of HIV infection with outcomes among adults hospitalized with COVID-19AIDS · 2021
137. Online Patient Education Materials Related to Lipoprotein(a): Readability AssessmentJournal of Medical Internet Research · 2021
138. COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort2021
139. Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patientsOpen Heart · 2021
140. Prioritizing Equity and Diversity in Academic Medicine Faculty Recruitment and RetentionJAMA Health Forum · 2021
141. Initial Outcomes of CardioClick, a Telehealth Program for Preventive Cardiac Care: Observational StudyJMIR Cardio · 2021
142. Associations of Insulin Resistance With Systolic and Diastolic Blood Pressure: A Study From the HCHS/SOLHypertension · 2021
143. Disparity in the Setting of Incident Heart Failure DiagnosisCirculation Heart Failure · 2021
144. Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD RegistryScientific Reports · 2021
145. Gender Disparities in Cardiology-Related COVID-19 PublicationsCardiology and Therapy · 2021
146. Increases in SARS-CoV-2 Test Positivity Rates Among Hispanic People in a Northern California Health SystemPublic Health Reports · 2021
147. National Trends and Disparities in Hospitalization for Hypertensive Emergencies Among Medicare Beneficiaries, 1999–20192021
148. Analysis of Female Enrollment and Participant Sex by Burden of Disease in US Clinical Trials Between 2000 and 2020JAMA Network Open · 2021
149. Automated coronary calcium scoring using deep learning with multicenter external validationSHILAP Revista de lepidopterología · 2021
150. Racial and Ethnic Disparities in Cardio-OncologyJACC CardioOncology · 2021